US Drugmaker Begins Late-Stage Testing of Single-Dose COVID-19 Vaccine in US
U.S. pharmaceutical giant Johnson & Johnson has begun late-stage human trials of a single-dose COVID-19 vaccine in the United States. Dr. Paul Stoffels, Johnson & Johnson’s chief scientific officer, told reporters Wednesday that 60,000 participants have begun receiving the vaccine across 215 locations in the United…